Wanve Sandip A, Andrade Neelam N, Venkatakrishnan Lakshmi, Desai Harsh
Nair Hospital Dental College, Mumbai, Maharashtra, India.
J Oral Biol Craniofac Res. 2023 May-Jun;13(3):436-441. doi: 10.1016/j.jobcr.2023.03.007. Epub 2023 May 8.
Odontogenic keratocysts (OKC) has a high potential for recurrence. Resection is currently the only fool-proof method to ensure that recurrence does not occur; however, it drastically affects the patient's function and aesthetics. Application of modified Carnoy's solution (MCS) as an adjunct to reduce the recurrence rate is currently in vogue. 5- Flurouracil (5-FU) is an anti-metabolite that has been used in the treatment of basal cell carcinoma and is relatively safer than MCS. The present study aims to compare the effectiveness of 5-UC and MCS in reducing the recurrence rate in OKC..
A total of 42 OKCs were enucleated followed by application of MCS (control group, n = 21) or 5-FU dressing (study group, n = 21) following enucleation. Pain, swelling, temporary and permanent paresthesia paresthesia, bone sequestrum formation, osteomyelitis and recurrence in both groups were evaluated at periodic intervals up to 12 months post-surgery.
There was no significant difference in terms of pain, or swelling in both groups. Permanent paresthesia and recurrence rates were higher in patients treated with MC but the difference was not statistically significant.
5-FU is an easy-to-use, feasible, biocompatible and cost-effective alternative for MCS in the management of OKCs. Treatment with 5-FU, therefore, reduces the risk of recurrence and also the post-surgical morbidity associated with other treatment procedures.
牙源性角化囊肿(OKC)具有较高的复发可能性。目前,切除是确保不复发的唯一可靠方法;然而,这会极大地影响患者的功能和美观。应用改良卡诺氏溶液(MCS)作为辅助手段以降低复发率目前很流行。5-氟尿嘧啶(5-FU)是一种抗代谢药物,已用于治疗基底细胞癌,且比MCS相对更安全。本研究旨在比较5-FU和MCS在降低OKC复发率方面的有效性。
共摘除42个OKC,摘除后对其中21例应用MCS(对照组),另外21例应用5-FU敷料(研究组)。在术后长达12个月的期间内定期评估两组的疼痛、肿胀、暂时性和永久性感觉异常、骨死骨形成、骨髓炎及复发情况。
两组在疼痛或肿胀方面无显著差异。接受MCS治疗的患者永久性感觉异常和复发率较高,但差异无统计学意义。
在OKC的治疗中,5-FU是一种易于使用、可行、生物相容性好且具有成本效益的替代MCS的方法。因此,5-FU治疗可降低复发风险以及与其他治疗程序相关的术后发病率。